RhoA/Rho-kinase pathway: much more than just a modulation of vascular tone. Evidence from studies in humans
Authors:
- Lorenzo A CalòLCLorenzo A Calò
- Achille C PessinaAPAchille C Pessina
- 1 February 2007
- journal article
- review article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 25 (2) , 259-264
Abstract
RhoA/Rho-kinase signaling and its relationship/balance with the nitric oxide level, angiotensin II and vasopressors for cardiovascular pathophysiology is of increasing importance, and its involvement goes far beyond blood pressure regulation. The deep involvement of this pathway in cardiovascular biology is now known to include a wide spectrum of conditions relating to the long-term complications of hypertension, and in general of cardiovascular pathophysiology, such as changes in cardiovascular structure (remodeling) and the induction of atherosclerosis, involvement in the pathophysiological relationships between inflammation and hypertension, and in those between hypertension, glucose metabolism and insulin resistance. Studies from our laboratory have made an important contribution to the understanding of the cellular and molecular mechanisms mediated by the RhoA/Rho-kinase pathway, which include all the aspects of cardiovascular pathophysiology in which this pathway plays a role. In addition, if it is considered that our contribution to the clarification of these mechanisms only comes from studies in humans, their impact on the scenario of the RhoA/Rho-kinase pathway's biology, essentially supported by studies 'in vitro' or in animal models, is immediate. This review examines all the aspects of RhoA/Rho-kinase signaling in the light of the available data, and gives an updated and useful overall picture of its involvement in cardiovascular pathophysiology.Keywords
This publication has 49 references indexed in Scilit:
- The role of the RhoA/Rho-kinase signaling pathway in renal vascular reactivity in endothelial nitric oxide synthase null miceJournal Of Hypertension, 2006
- Reduced mRNA and Protein Content of Rho Guanine Nucleotide Exchange Factor (RhoGEF) in Bartter’s and Gitelman’s Syndromes: Relevance for the Pathophysiology of HypertensionAmerican Journal of Hypertension, 2005
- Rho kinase and PAI-1 in Bartter's/Gitelman's syndromesJournal Of Hypertension, 2004
- Ca2+Sensitivity of Smooth Muscle and Nonmuscle Myosin II: Modulated by G Proteins, Kinases, and Myosin PhosphatasePhysiological Reviews, 2003
- RhoA Expression Is Controlled by Nitric Oxide through cGMP-dependent Protein Kinase ActivationJournal of Biological Chemistry, 2003
- The role of RhoA and Rho-associated kinase in vascular smooth muscle contractionCurrent Hypertension Reports, 2003
- Rho-Kinase Mediates Hypoxia-Induced Downregulation of Endothelial Nitric Oxide SynthaseCirculation, 2002
- Possible Involvement of Rho-Kinase in the Pathogenesis of Hypertension in HumansHypertension, 2001
- Increased urinary NO2−/NO3− and cyclic guanosine monophosphate levels in patients with bartter's syndrome: Relationship to vascular reactivityAmerican Journal of Kidney Diseases, 1996
- Inositol trisphosphate and calcium signallingNature, 1993